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Behc ¸et’s disease (BD) is a vasculitic disorder of relapsing acute inﬂammation characterized by recurrent oral ulcers, genital
ulcers, uveitis, and skin lesions. The disease also aﬀects other organs, including joints, the nervous system, blood vessels, and
gastrointestinal (GI) system may also be involved and the lower GI tract is the mostly involved part, leading to severe morbidity.
The frequency of GI involvement in BD varies among diﬀerent ethnic groups. Although 50–60% of Japanese patients have GI
disease, these manifestations are rare in patients from Mediterranean countries. The gastrointestinal manifestations of BD usually
appear 4.5–6 years after the onset of the oral ulcers. The intestinal lesions are usually resistant to medical treatment and recur after
surgery.Theelementarylesionisapthousulcer. Deep,roundorovalulcerswithapunched-outappearancetendtoperforateeasily,
so that many patients require urgent operation.
1.Introduction
Behc ¸et’s Disease (BD) is a chronic rheumatic disease, in
which unpredictable inﬂammatory episodes of orogenital
and ocular inﬂammation (or ulceration) are induced by the
body’s overreactive immune system, was ﬁrst reported in
1937 by Hulusi Behc ¸et.
Patients with incomplete form of Behc ¸et’s syndrome
without ocular involvement, according to Morita et al., had
been well described in the Japanese population [1]. Coun-
tries with a high prevalence of BD cluster along the ancient
silk road from Eastern Asia to the Mediterranean Basin.
Young adults between the second and fourth decades
of life are mainly aﬀected [2]. In children, this type of BD
occurs very rarely, usually as the perianal aphthous lesions
that appear to be a speciﬁc feature of childhood BD [3].
Behc ¸et’sdiseaseismorecommonandmoresevereinmen
than in women in the ancient Silk Road countries, whereas
in Western Europe and the USA, it is equivalent between
the sexes or more common in women [2]. Populations has
yielded interesting epidemiological ﬁndings: Turkish indi-
viduals who have emigrated to Germany have a signiﬁcantly
lower risk of disease than individuals of Turkish origin living
in Turkey, although their risk remains higher than that of the
native German population.
The most plausible environmental trigger is an infectious
agent, for that reason evidence of viral infection has been
sought. Increased rates of anti-Saccharomyces cerevisiae
antibodies (ASCAs); which are recently proposed serologic
markers of disease and commonly associated with Crohn’s
disease (CD), were previously reported by several studies in
BD [4]. However these antibodies are present in 44% of BD
patientswhohaveintestinalinvolvementofthedisease,com-
paredwith3%inpatientswithoutgastrointestinalsymptoms
[5]. Alternatively, BD may be primarily autoimmune in or-
igin [4]. Various genetic markers have been identiﬁed, espe-
ciallyregardingtumornecrosisfactor-α(TNF-α)andvarious
proinﬂammatory cytokine polymorphisms. Recent reports
have focused on the TNF-∞ gene, which is closely linked to
the HLA-B51 gene, in view of the major role played by this
proinﬂammatory cytokine in BD. In the Turkish population,
the TNF-∞1031C allele was associated with susceptibility to
Behc ¸et’s disease [5].
Pathologically the disease is characterasized by vasculitis
targeting the vasa vasorum and other small blood vessels,
which is usually lymphocytic and aﬀects veins more than
arteries, although occasionally there may be more necro-
tizing inﬂammation with leucocytoclasis. Fibrinoid necrosis
may be present in involved veins and venules [6]. There is
intense inﬂammation around the vasa vasorum, resulting in2 Pathology Research International
destructionofthemediaandﬁbrousthickeningoftheintima
and adventitia. Pseudoaneurysms are the most common
arterial manifestations, mainly involving the aorta, the pul-
monary, and femoral arteries [2]. While thrombophlebitis of
the superﬁcial and deep veins is common in BD, thrombosis
and aneurysms of the large arteries in the abdominal cavity
are rare but lead to death [7].
Diagnostic criteria of BD are deﬁned by the1990 Interna-
tionalStudyGroupforBD.Recurrentoralulcerationmustbe
present along with two of the followings: genital ulcerations,
typical eye lesions, typical skin lesions, or positive pathergy
test [2–5].
2. GastrointestinalManifestations of
Behc ¸et’sDisease
The gastrointestinal manifestations of BD usually appear
4.5–6 years after the onset of the oral ulcers [3]. The most
frequently aﬀected site in GI system is the ileocecal region,
with extension into the ascending colon. Common clinical
symptoms include abdominal pain, diarrhea, and bleeding,
similar to those of inﬂammatory bowel disease [8]. The fre-
quencies of GI involvement vary among diﬀerent ethnic
groups.InJapanandKorea,theprevalenceofGIinvolvement
is higher (50–60%), whereas in Turkey and Israel the prev-
alence is much lower (0–5%) [9, 10]. In the series of 2313
BD patients of Tursen et al. GI involvement was found in
31 patients (1.4%) [11]. Intestinal involvement in BD is rare
but important because it is one of the most common causes
of fatality, and severe morbidity during the course of the
disease [9]. Intestinal BD can be diagnosed if a patient shows
typical ulcer in the small or large intestine, and if systemic
manifestations meet the diagnostic criteria of BD [12]. The
genetic and environmental factors inﬂuence the frequencies,
but the series so far reported included only small numbers of
cases and were not standardized [13].
GI symptoms are often caused by nonspeciﬁc ulcers.
While all patients develop oral lesions, it is the presenting
manifestation in about 70% of patients [2]. However, these
lesions are not pathognomonic of BD and can be seen in
a variety of other clinical conditions such as anemia, avita-
minosis, viral infections, inﬂammatory bowel disease, and
Reiter syndrome. The oral ulcers of BD are aphthous or
herpetiform, and occur at least three times a year in the
absence of other clinical explanations for the ulcers [3]. The
lesions are punched-out ulcers with rolled or overhanging
edges and a necrotic base, surrounded by an erythematous
rim. They are generally painful and heal with little scarring,
with or without treatment [2]. Moreover, the recurrent oral
ulcerations of BD tend to be multiple and usually involve the
soft palate and oropharynx [3]. Smoking may decrease the
severity of ulceration in BD. Histologically, there is vasculitis
with an inﬁltration of monocytes and lymphocytes early
in the disease and neutrophils in older lesions. Additional
ﬁndings are ﬁbrinoid necrosis, endothelial swelling, and a
perivascular inﬁltrate in both early and late lesions [2].
Esophageal involvement is uncommon. However, upper
GI involvement may be underestimated because endoscopic
examination is not performed routinely in BD and there are
few clinical trials investigating the upper GI tract in BD [14].
Since the ﬁrst case of esophageal ulceration of this syndrome
was presented by Brodie and Ochsner in 1973, to date, less
than 50 cases of Behc ¸et’s patients with esophageal ulcers have
been reported worldwide [15]. Houman et al. studied 23
patients with BD (four with upper GI symptoms) and found
endoscopic, manometric, and/or microscopic abnormalities
in 14 patients; histopathologic abnormalities were found in
only ﬁve patients. They concluded that the prevalence of
esophageal involvement in BD was high but these ﬁndings
were not conﬁrmed by other studies [14]. It usually involves
the middle part of the esophagus, causing substernal pain,
dysphagia, and occasionally hematemesis, although diﬀuse
esophagitis and stenosis have also been reported [2, 15]. The
esophageal ulcerations in BD can be single or multiple, and
are oftenassociated withulcers in other parts of the gastroin-
testinaltract.Esophageallesionsreportedtooccurinpatients
with BD are (1) linear, oval, or round ulcerations similar to
those that are present in the mouth, (2) ulcers or ﬁstula that
communicatewithadjacentorganssuchastrachea,(3)lumi-
nal strictures, a pseudomembranous esophagitis, and (4)
“downhill,” or classical, esophageal varices associated with
either superior vena caval obstruction or portal hyperten-
sion due to portal vein thrombosis [3]. In addition, serious
complications such as stricture, bleeding, or perforations
have been rarely described [15]. Histology is nonspeciﬁc,
showing lymphocytic or neutrophilic inﬁltration rather than
vasculitis. The lesions may be resistant to treatment with
a proton pump inhibitor but resolve with corticosteroids.
Since BD is treated with immunosuppressive agents, viral, or
candida esophagitis should be excluded [2].
The stomach is the least frequently involved part of
the GI tract. An exception is the surprisingly high number
of Taiwanese patients with BD (45%) who have gastric or
duodenal ulcers [2]. Ning-Seng et al. found a close relation-
ship between A2/B46/Cw1 (or A11/B46/Cw1) genotype and
the development of gastric/duodenal ulcers [16]. Aphthous
ulcers are the most common ﬁnding however there may be
pyloric stenosis due to edematous hypertrophy of the pyloric
ring or a Dieulafoy’s ulcer [2]. Two studies assessing the fre-
quency of Helicobacter pylori (H. pylori) infection in Turkish
patientswithBDhavebeenreportedwithanureasepositivity
rate of 65% in the ﬁrst and 85% in the second report and
the presence of H. pylori correlated with the disease activity,
manifested as the presence of gastrointestinal complaints or
endoscopic ﬁndings [3]. In their study, C ¸akmak et al. suggest
that the prevalence of upper GI abnormalities in BD is high
andmayoccurinasymptomaticpatients,butthatabnormal-
ities are not speciﬁc for BD. Therefore, routine endoscopy
and screening for H. pylori infection may not be necessary in
asymptomatic patients [17]. In one report, treatment of H.
pylori diminished the oral and genital ulcers. Furthermore
gastric pathogen H. pylori produces heat shock proteins
which is thought to play a role in the etiopathogenesis of BD
and may cause ulcers in the GI tract [18].
The intestinal lesions of BD occur in two forms: mucosal
inﬂammation and ischemia/infarction. The clinical presen-
tation of intestinal BD is similar to that of CD, which sharesPathology Research International 3
Figure 1: Endoscopically detected pseudopolips in small intestine
mucosa (with permission of Dr. O Sezgin).
manyextraintestinalfeaturessuchasorallesions,uveitis,and
arthritis. The other stigmata of BD may appear later than the
gastrointestinal features. Thus, in areas of the world where
BD is common ileocolitis should be followed closely for the
other major stigma of BD and should be assumed to be a
manifestation of idiopathic inﬂammatory bowel disease [3].
The small intestine is the most frequently involved ex-
traoral part of the gastrointestinal tract in cases of BD. The
lesions are most commonly found in the terminal ileum,
particularly in the area of lymphoid aggregates and Peyer’s
patches, and the cecum, and less frequently in the colon.
Rectal and anal involvement is quite rare. Intestinal lesions
are located on the antimesenteric side [19]. Ileocecal in-
volvement in cases of BD is common in Japan and Turkey,
while colonic involvement is the usual pattern in Europe and
North America [3]. Isolated involvement of the ileum is not
uncommon in BD. Ileal visualization should be performed
atcolonoscopicexaminationinclinicalpracticetodocument
theintestinalinvolvement.MostofthepatientswithBDhave
inﬂammation in the ileum, even in the absence of visible
lesions [13]. The most common colonoscopic ﬁndings are
localizedsingleormultipleulcersintheileocecalregion,with
only 4% having a diﬀuse distribution of lesions (Figures 1,
and 2). The ulcers may be aphthous or, alternatively, deep
and round with a punched-out appearance. They are usually
localized but multiple in number and may resolve with
medical therapy. Longitudinal ulcers are rare. Fissuring and
linear ulcers up to 5cm long may also be present. Enlarging
or newly formed ulcers coexist with healed ulcers. They have
a tendency to irregularly undermine surrounding tissues.
Edema-like swelling with crater formation around the ulcer
margins produces a characteristic “collar-stud”appearance
[20]. Adjacent to larger ulcers there are often smaller aphtoid
ulcers. BD is particularly charecterized by adjcent macro-
scopically normal-appearing mucosa [6]. Multiple superﬁ-
cial ulcers located predominantly in the terminal ileum in
Turkish patients diﬀer from the single, large, deep ulcers
with distinct borders described in the Far East. By the way,
intestinal perforations may occur more commonly in Far
Figure 2: Endoscopically detected ulcers in small intestine mucosa
(with permission of Dr. O Sezgin).
Figure 3:Macroscopicspecimenshowinghemorrhagicareasonthe
serosal surface and perforation (arrow) (with permission of Dr. DS
Arici).
East patients than West [12, 19, 21]( Figure 3)[ 22]. The
exactperforationmechanisminintestinalBDisnotclear,but
there are several hypotheses. First, typical large, discrete, and
excavated ulcers penetrate, resulting in perforation. Second,
bowel dilatation may lead to perforation. Third, long-term
steroid use may be associated with the development of bowel
perforation.J.Chouetal.reportedaseriesof22patientswith
multiple intestinal perforations [23].
The colonic ulcers in BD have been classiﬁed as volcano-
type, geographic, and aphthous. Volcano-type ulcers were
deﬁned as well-demarcated deeply penetrating ulcers with
nodular margins, converging folds, or pseudopolyps. Geo-
graphic-type ulcers were deﬁned as shallow ulcers with sharp
edges, while aphthous-type ulcers were small, punched-
out shallow ulcers. Volcano-type ulcers had a less favorable
response to medical treatment, more frequent requirement
for surgery, and more frequent recurrences than the other
two types [2]. Histologically, vasculitis of the small veins
and venules is common in cases of intestinal BD. It is
characterized by a lymphocytic inﬁltrate (Figures 4,a n d5)
[22]. However, chronic nonspeciﬁc (sometimes transmural4 Pathology Research International
Figure 4:Histopathologicexaminationshowednonspeciﬁcinﬂam-
matory cell inﬁltration surrounding the vessels (HE ×25) (with
permission of Dr. DS Arici).
and granulomatous) inﬂammation with a normal interven-
ing mucosal area may make it diﬃcult to distinguish BD
from CD. Focal colitis has been documented in colorectal
biopsies obtained from patients with BD but without visual
or clinical evidence of rectal involvement demonstrable by
either endoscopic or radiologic examinations.
The abdominal complaints that lead to surgical interven-
tion are abdominal pain (92%), an abdominal mass (21%),
and/ormelena(17%)[3].Histopathologically,Behc ¸et’sulcers
contain nonspeciﬁc chronic inﬂammation, and the submu-
cosal connective tissue appears disrupted. Granulomas are
absent. The mucosa around the ulcers is usually normal in
appearance [20]. The presence of focal ulcers, ﬁstulae, and
strictures and the ileocecal location may mimic CD. Since
the histologic features are nonspeciﬁc, one must rely on the
clinician to suggest the diagnosis. Just like the case reported
by Jarrahnejjad et al., the patient can be misdiagnosed
as having ulcerative colitis until pathological diagnosis of
vasculitis is determined [20, 24]. However, Kim et al. suggest
that inﬂammatory bowel diseases and Behc ¸et’s disease may
be closely related and part of a spectrum of disease rather
than distinct disease entities [25].
There may also be perienteric inﬁltration, mild lym-
phadenopathy, mesenteric vascular engorgement, mild sple-
nomegaly, and minimal ascites. Complications of bowel per-
foration and peritonitis occur more commonly in patients
with a thickened bowel wall and severe perienteric inﬁltra-
tion rather than those with polypoid lesions. Although many
patients with BD have abdominal pain similar to appendici-
tis, the distinction can often be made with CT scanning.
MRI also demonstrates bowel wall thickening and increased
enhancement as well as extraluminal manifestations such as
mesenteric inﬁltration around the involved bowel. Indium-
111-labeled leukocytes can demonstrate localization in an
area of inﬂammation [2].
2.1. Pancreas. A patient with BD can develop features
consistent with either acute or chronic pancreatitis. Other
etiologic factors for pancreatitis such as gallstone, alcohol,
trauma, hyperlipidemia, and an infectious disease process
should be ruled out before accepting the case as being related
to BD. Biochemical evidence of pancreatitis can occur in
Figure 5: Mucosal ulceration (H&E ×10) (with permission of Dr.
DS Arici).
the absence of either sonographic or computer tomographic
ﬁndings and is a relatively common occurrence in cases of
BD [2]. Acute pancreatitis may respond to corticosteroids.
2.2. Liver. The most common hepatic complication of BD is
Budd-Chiari syndrome (BCS). BCS is an uncommon form
of portal hypertension caused by obstruction of the hepatic
venous outﬂow usually due to thrombi in the hepatic veins.
The main clinical features are hepatomegaly, leg edema,
ascites, and venous dilatation over the trunk. The radiologic
and liver biopsy ﬁndings conﬁrm the diagnosis and provide
information for the selection of appropriate medical, inter-
ventional, or surgical therapies. Because vasculitis is a major
pathologic component of BD, hepatic vein vasculitis and
BCS occur often in cases of BD. However, with no histologic
evidence of vasculitis, a case of bile duct inﬂammation re-
sembling small duct primary sclerosing cholangitis has been
also reported.
The study of Bayraktar et al. is the largest series in the
literature, consisting of 14 cases of BD-associated BCS. Based
on this experience, it appears as if BCS is a relatively frequent
complication of BD that accounts for 42.4% of the cases of
BCS with recognizable underlying disease in Turkey. In most
patients with BD and BCS, the IVC, as well as the hepatic
veins, is involved. The clinical course of BCS in BD is poor
[3]. The major determinant of survival is the extent of the
vascular thrombosis in the IVC. BD may also contribute to
development of cavernous transformation of the portal vein,
portalveinthrombosiswithsplenomegaly,andsuperiorvena
cava thrombosis.
The other hepatobiliary conditions reported to occur in
casesofBDarehepatomegalyduetofattyliverorcongestion,
cirrhosis, acute hepatitis, chronic hepatitis, cholelithiasis,
acute cholecystitis, toxic hepatitis, hepatic abscess, primary
biliary cirrhosis, and hepatocellular carcinoma. Acute liver
failure and rapid death were found in one-third of patients
in one series. M¨ unke et al., suggested an association between
BD and chronic hepatitis C [26]. Subsequently, O˘ guz et
al. reported a 0.45% prevalence of anti-HCV antibodies in
as e r i e so f2 2 4c a s e so fB Di nT u r k e y[ 27]. They stated
that this ﬁnding is similar to the prevalence of anti-HCV
that occurs in healthy subjects and is much lower thanPathology Research International 5
the prevalence in hemodialysis patients (51%) [3]. Rare cases
include a hepatic artery aneurysm causing hemobilia as well
as pylephlebitis and septic thrombophlebitis of the portal
vein. Type AA amyloidosis complicates BD and presents
most often as diarrhea and malabsorption. It mainly involves
the GI tract and the kidneys with proteinuria that progresses
to nephrosis and renal failure. It has a 50% mortality rate
after an average duration of 3.4 years.
3. DifferantialDiagnosis
Behc ¸et’s disease should be considered in the diﬀerential
diagnosis in patients with recurrent orogenital ulcerations
and enterocolitis with a nonspeciﬁc histological feature [28].
3.1.Crohn’sDisease. ThediagnosisofBehc ¸etdiseaserequires
the presence of recurrent oral ulceration. Other helpful clini-
cal features include ocular involvement, arthritis, erythema
nodosum, and recurrent genital ulceration. Unfortunately,
some of these may also be present in CD [20]. While
granulomaformationisapathologichallmarkofCD,itisnot
a characteristic lesion of BD just like cobblestoning and there
islessinﬂammationsurronding ulcerinBDcomparedtoCD
[12]. Longitudinal ulcers and granulomas tend to be uncom-
m o ni nB e h c ¸et’s colitis, Naganuma et al. reported intestinal
Behc ¸et’s disease with longitudinal ulcers and noncaseating
granuloma [29]. The most characteristic pathologic feature
of BD is the ﬁnding of deep ulcers associated with vasculitis,
usually a venulitis [12]. The intestinal wall is of normal
thickness, unlike the rigid, narrowed segments seen in CD.
In addition, ﬁstula formation and intestinal perforation tend
to occur early in BD as compared to CD where they occur
in a later course of the disease. Free perforation is rare in
cases of CD but can occur in BD. Korman et al. found that in
CD, but not in BD, enteroclysis, a radiologic examination of
choice in the detection of pathologic changes in small bowel
thatshowsthesiteandextensionoftheinvolvement,mucosal
abnormalities, complications, and recurrences, ﬁndings were
more severe, and cases generally were in the advanced stage
when compared with the duration of both diseases [9].
Scalloping, ulceronodular patterns, and complications such
as abscess formation are not observed in intestinal BD,
thereforecertainECﬁndingsarehelpfulindiﬀerentiatingBD
from CD.
3.2. Steroid and Nonsteroid Anti-Inﬂammatory Drug-Induced
Damage. Steroid and nonsteroid anti-inﬂammatory drug-
(NSAID-) induced damage involves primarily proximal large
intestine and occurs in various forms including colitis, co-
lonic ulcers, pseudomembranous colitis, collagenous colitis,
bleeding, and perforation, while aphthous ulceration is very
rare. NSAIDs may occasionally cause small intestinal perfo-
ration, ulcers, and strictures that require surgery. The pa-
tient’s clinical history is important since many patients with
BD use steroids to control their disease. The ulcers that occur
in cases of BD diﬀer from steroid-induced ulcers both in
size and appearance. Steroid-induced ulcer is usually single
while the ulcers of BD seen in long-term steroid treatment
are characterized by multiple perforations. In one study, the
frequency of intestinal perforation in patients with BD on
steroids was 41%. Also in cases of BD without a history of
steroid use, intestinal perforation can occur in up to 33% of
the patients [12].
3.3. Ulcerative Colitis. The ileocecal region is the most
frequently involved location in colonic BD. However, in
ulcerative colitis the disease usually starts in the rectum and
movestotherightcolon,andalsotheulcersaredeeperinBD
thanulcerativecolitis[12].Furthermore,HLA-B51hasnever
been reported in association with ulcerative colitis. Rather
signiﬁcant association with B52 and DR2 with UC has been
reported [30].
3.4. Amebiasis. Diﬀerantion of amebiasis and BD is impor-
tant in the Middle East where both were frequently occur.
Endoscopically, the disease is diﬀuse in both conditions, and
the mucosa is hyperemic and is characterized by deep ulcers.
But the presence of an amoeba in a fresh stool specimen is
the best way to diﬀerentiate the two conditions [12].
4.PrognosisandTreatment
Prognosis of BD runs a chronic, unpredictable course with
exacerbations and remissions which decrease in frequency
and severity over time. Death is mainly due to major vessel
disease and neurological involvement. The prognosis is poor
for young males. Treatment of BD is usually palliative and
symptomatic. The preferred treatments are combined drug
therapy with any or all of the following: steroids, NSAIDs,
immunosuppressives, and cytotoxic agents [20]. Complete
remission is achieved in 38% of patients with intestinal BD
after 8 weeks of medical treatment. Surgery is the other
modality of treatment. Recurrence occurs in 49% of patients
in 5 years, especially those with intestinal perforation or
ﬁstula formation. Recurrent lesions ocur at or near the anas-
tomoses in 1% of patients. Of those who undergo surgery,
75% recur within 2 years and are associated with a higher
rate of complications such as ocular and ileal lesions than
the nonsurgical group. The incidence of postoperative recur-
rence is less in those with normal intraoperative endoscopy
than those with lesions seen. High rate of recurrent disease is
observed especially in patients of Western or Chinese origin
[15].Thehistologicfeaturesofrecurrentdiseaseresemblethe
primary disease.
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